Prelude Therapeutics (NASDAQ:PRLD) announced its Q4 earnings on Tuesday, March 10, 2026 at 07:01 AM.

Here's a breakdown of the earnings report.

Earnings

Prelude Therapeutics beat estimated earnings by 16.67%, reporting an EPS of $-0.2 versus an estimate of $-0.24.

Revenue was up $1.64 million from the same period last year.

Analysis of Past Earnings

Last quarter the company beat on EPS by $0.09 which was followed by a 2.72% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Prelude Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.